$109 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 334 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OLK | Exit | OLINK HLDG ABsponsored ads | $0 | – | -29,500 | -100.0% | 0.00% | – |
| TWOU | Exit | 2U INC | $0 | – | -75,000 | -100.0% | 0.00% | – |
| TUEM | Exit | TUESDAY MORNING CORP | $0 | – | -1,067,000 | -100.0% | 0.00% | – |
| VRNS | Exit | VARONIS SYS INC | $0 | – | -46,340 | -100.0% | -0.00% | – |
| CE | Exit | CELANESE CORP DEL | $0 | – | -8,000 | -100.0% | -0.00% | – |
| CRNC | Exit | CERENCE INC | $0 | – | -190,125 | -100.0% | -0.00% | – |
| TWTR | Exit | TWITTER INC | $0 | – | -160,700 | -100.0% | -0.01% | – |
| SAIC | Exit | SCIENCE APPLICATIONS INTL CO | $0 | – | -115,900 | -100.0% | -0.01% | – |
| PNR | Exit | PENTAIR PLC | $0 | – | -667,100 | -100.0% | -0.03% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -1,506,272 | -100.0% | -0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
| BIOGEN INC. | 42 | Q3 2023 | 6.8% |
| AMGEN INC. | 42 | Q3 2023 | 5.3% |
| MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
| ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
| TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
| FEDEX CORP | 42 | Q3 2023 | 3.3% |
| SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
| NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
| MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
| STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
| Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
| CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
| COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
| STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
| Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
| NN INC | November 09, 2022 | 1,763,640 | 4.0% |
| AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
| Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.